151 related articles for article (PubMed ID: 2999255)
1. Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine.
Dummer JS; White LT; Ho M; Griffith BP; Hardesty RL; Bahnson HT
J Infect Dis; 1985 Dec; 152(6):1182-91. PubMed ID: 2999255
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus infections in renal, heart, heart-lung and liver transplantation.
Pollard RB
Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S97-102. PubMed ID: 2456512
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus infections in heart and heart-lung transplant recipients.
Wreghitt T
J Antimicrob Chemother; 1989 Jun; 23 Suppl E():49-60. PubMed ID: 2550412
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus infections in heart and heart and lung transplant recipients.
Wreghitt TG; Hakim M; Gray JJ; Kucia S; Wallwork J; English TA
J Clin Pathol; 1988 Jun; 41(6):660-7. PubMed ID: 2838530
[TBL] [Abstract][Full Text] [Related]
5. Infectious complications in heart-lung transplant recipients.
Brooks RG; Hofflin JM; Jamieson SW; Stinson EB; Remington JS
Am J Med; 1985 Oct; 79(4):412-22. PubMed ID: 2996346
[TBL] [Abstract][Full Text] [Related]
6. DHPG effectively treats CMV infection in heart and heart-lung transplant patients: a preliminary report.
Icenogle TB; Peterson E; Ray G; Minnich L; Copeland JG
J Heart Transplant; 1987; 6(4):199-203. PubMed ID: 2822880
[TBL] [Abstract][Full Text] [Related]
7. The importance of cytomegalovirus in heart-lung transplant recipients.
Hutter JA; Scott J; Wreghitt T; Higenbottam T; Wallwork J
Chest; 1989 Mar; 95(3):627-31. PubMed ID: 2537711
[TBL] [Abstract][Full Text] [Related]
8. Three-year experience with human cytomegalovirus infections in heart transplant recipients.
Grossi P; Revello MG; Minoli L; Percivalle E; Zavattoni M; Poma G; Martinelli L; Gerna G
J Heart Transplant; 1990; 9(6):712-9. PubMed ID: 2177498
[TBL] [Abstract][Full Text] [Related]
9. Should heart-lung transplant donors and recipients be matched according to cytomegalovirus serologic status?
Novick RJ; Menkis AH; McKenzie FN; Reid KR; Ahmad D
J Heart Transplant; 1990; 9(6):699-706. PubMed ID: 2177496
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus infection and survival in lung transplant recipients.
Duncan AJ; Dummer JS; Paradis IL; Dauber JH; Yousem SA; Zenati MA; Kormos RL; Griffith BP
J Heart Lung Transplant; 1991; 10(5 Pt 1):638-44; discussion 645-6. PubMed ID: 1659899
[TBL] [Abstract][Full Text] [Related]
11. Active CMV infection before lung transplantation: risk factors and clinical implications.
Milstone AP; Brumble LM; Loyd JE; Ely EW; Roberts JR; Pierson RN; Dummer JS
J Heart Lung Transplant; 2000 Aug; 19(8):744-50. PubMed ID: 10967267
[TBL] [Abstract][Full Text] [Related]
12. Use of cytomegalovirus (CMV) hyperimmune globulin for prevention of CMV disease in CMV-seropositive lung transplant recipients.
Zamora MR; Fullerton DA; Campbell DN; Leone S; Diercks MJ; Fisher JH; Badesch DB; Grover FL
Transplant Proc; 1994 Oct; 26(5 Suppl 1):49-51. PubMed ID: 7940974
[TBL] [Abstract][Full Text] [Related]
13. Combined cytomegalovirus prophylaxis in lung transplantation: effects on acute rejection, lymphocytic bronchitis/bronchiolitis, and herpesvirus infections.
Solidoro P; Libertucci D; Delsedime L; Ruffini E; Bosco M; Costa C; Rinaldi M; Baldi S
Transplant Proc; 2008; 40(6):2013-4. PubMed ID: 18675117
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus-specific cell-mediated immune responses in heart and heart-lung transplant recipients are not predictive for the occurrence of symptomatic CMV disease or tissue rejection.
van Tiel FH; Rasmussen L; Merigan TC
J Interferon Res; 1991 Aug; 11(4):221-9. PubMed ID: 1655916
[TBL] [Abstract][Full Text] [Related]
15. Incidence of cytomegalovirus disease in cyclosporine-treated renal transplant recipients based on donor/recipient pretransplant immunity.
Weir MR; Irwin BC; Maters AW; Genemans G; Shen SY; Charache P; Williams GM
Transplantation; 1987 Feb; 43(2):187-93. PubMed ID: 3027930
[TBL] [Abstract][Full Text] [Related]
16. Infections in heart-lung transplant recipients.
Dummer JS; Montero CG; Griffith BP; Hardesty RL; Paradis IL; Ho M
Transplantation; 1986 Jun; 41(6):725-9. PubMed ID: 3012834
[TBL] [Abstract][Full Text] [Related]
17. Mononuclear subsets during cytomegalovirus disease in renal transplant recipients treated with cyclosporine and rabbit antithymocyte globulin.
Metselaar HJ; Rothbarth PH; Wenting GJ; Vaessen LB; Masurel N; Jeekel J; Weimar W
J Med Virol; 1986 May; 19(1):95-100. PubMed ID: 3009707
[TBL] [Abstract][Full Text] [Related]
18. Blood cyclosporine concentrations and cytomegalovirus infection following heart transplantation.
Best NG; Trull AK; Tan KK; Spiegelhalter DJ; Wreghitt TG; Wallwork J
Transplantation; 1995 Oct; 60(7):689-94. PubMed ID: 7570978
[TBL] [Abstract][Full Text] [Related]
19. Management of cytomegalovirus antibody negative patients undergoing heart transplantation.
Freeman R; Gould FK; McMaster A
J Clin Pathol; 1990 May; 43(5):373-6. PubMed ID: 2164531
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus infection rate among heart transplant patients in relation to anti-thymocyte immunoglobulin induction therapy. Copenhagen Heart Transplant Group.
Krogsgaard K; Boesgaard S; Aldershvile J; Arendrup H; Mortensen SA; Petterson G
Scand J Infect Dis; 1994; 26(3):239-47. PubMed ID: 7939422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
